Bioporto A/S logo

BIOPOR - Bioporto A/S News Story

DKK5.22 -0.2  -2.8%

Last Trade - 10:11am

Sector
Industrials
Size
Small Cap
Market Cap £167.6m
Enterprise Value £156.3m
Revenue £2.71m
Position in Universe 759th / 1830

Managers’ transactions

Wed 21st October, 2020 8:19am
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20201021:nGNE43nS4z


October 21, 2020 
Announcement no. 20

Managers’ transactions

In connection with the completion of BioPorto A/S’ rights issue as described
in company announcement no. 19, BioPorto has received notification pursuant to
article 19 of Regulation (EU) no. 596/2014 of the below transactions related
to shares in BioPorto A/S made by persons with managerial responsibilities in
BioPorto A/S and/or persons closely related with them.

 1. Details of the person discharging managerial responsibilities/person closely associated                                                                                                                                  
 a) Name                                                                                 Christopher James Lindop                                                                                                            
 2. Reason for the notification                                                                                                                                                                                              
 a) Position/status                                                                      Member of the Board of Directors of BioPorto A/S                                                                                    
 b) Initial notification/amendment                                                       Initial notification                                                                                                                
 3. Details of the issuer                                                                                                                                                                                                    
 a) Name                                                                                 BioPorto A/S                                                                                                                        
 b) LEI                                                                                  5299004SWFL5JAN4W830                                                                                                                
 4. Details of the transaction(s)                                                                                                                                                                                            
 a) Description of the financial instrument, type  of instrument    Identification code  Shares    ISIN code DK0061409042 to be merged with permanent ISIN code DKDK0011048619, expectedly no later than on 21 October 2020  
 b) Nature of the transaction                                                            Purchase (exercise of subscription rights in connection with rights issue)                                                          
 c) Price(s) and volume(s)                                                               Price: DKK 1.6, Volume: 111,621                                                                                                     
 d) Aggregated information * Aggregated volume                                           N/A                                                                                                                                 
 * Aggregated price                                                                                                                                                                                                          
 e) Date of the transaction                                                              2020-10-21 8.30 a.m. UTC (10:30 a.m. CEST)                                                                                          
 f) Place of the transaction                                                             Nasdaq Copenhagen A/S, XCSE                                                                                                         



 1. Details of the person discharging managerial responsibilities/person closely associated                                                                                                                                  
 a) Name                                                                                 Ole Larsen                                                                                                                          
 2. Reason for the notification                                                                                                                                                                                              
 a) Position/status                                                                      Chief Financial Officer of BioPorto A/S                                                                                             
 b) Initial notification/amendment                                                       Initial notification                                                                                                                
 3. Details of the issuer                                                                                                                                                                                                    
 a) Name                                                                                 BioPorto A/S                                                                                                                        
 b) LEI                                                                                  5299004SWFL5JAN4W830                                                                                                                
 4. Details of the transaction(s)                                                                                                                                                                                            
 a) Description of the financial instrument, type  of instrument    Identification code  Shares    ISIN code DK0061409042 to be merged with permanent ISIN code DKDK0011048619, expectedly no later than on 21 October 2020  
 b) Nature of the transaction                                                            Purchase (exercise of subscription rights in connection with rights issue)                                                          
 c) Price(s) and volume(s)                                                               Price: DKK 1.6, Volume: 108,468                                                                                                     
 d) Aggregated information * Aggregated volume                                           N/A                                                                                                                                 
 * Aggregated price                                                                                                                                                                                                          
 e) Date of the transaction                                                              2020-10-21 8.30 a.m. UTC (10:30 a.m. CEST)                                                                                          
 f) Place of the transaction                                                             Nasdaq Copenhagen A/S, XCSE                                                                                                         



 1. Details of the person discharging managerial responsibilities/person closely associated                                                                                                                                  
 a) Name                                                                                 Therazone ApS                                                                                                                       
 2. Reason for the notification                                                                                                                                                                                              
 a) Position/status                                                                      Closely associated person to Thomas Magnussen, Chairman of the Board of Directors of BioPorto A/S                                   
 b) Initial notification/amendment                                                       Initial notification                                                                                                                
 3. Details of the issuer                                                                                                                                                                                                    
 a) Name                                                                                 BioPorto A/S                                                                                                                        
 b) LEI                                                                                  5299004SWFL5JAN4W830                                                                                                                
 4. Details of the transaction(s)                                                                                                                                                                                            
 a) Description of the financial instrument, type  of instrument    Identification code  Shares    ISIN code DK0061409042 to be merged with permanent ISIN code DKDK0011048619, expectedly no later than on 21 October 2020  
 b) Nature of the transaction                                                            Purchase (exercise of subscription rights in connection with rights issue)                                                          
 c) Price(s) and volume(s)                                                               Price: DKK 1.6, Volume: 311,220                                                                                                     
 d) Aggregated information * Aggregated volume                                           N/A                                                                                                                                 
 * Aggregated price                                                                                                                                                                                                          
 e) Date of the transaction                                                              2020-10-21 8.30 a.m. UTC (10:30 a.m. CEST)                                                                                          
 f) Place of the transaction                                                             Nasdaq Copenhagen A/S, XCSE                                                                                                         

For further information, please contact:

Peter Mørch Eriksen, CEO 
Ole Larsen, CFO 
Telephone +45 4529 0000, e-mail: investor@bioporto.com

About BioPorto 
BioPorto is an in vitro diagnostics company that provides tests and antibodies
to clinicians and researchers around the world. We use our antibody and assay
expertise to transform novel research tools into clinically actionable
biomarkers that can make a difference in patients’ lives. BioPorto is
headquartered in Hellerup, Denmark and is listed on the NASDAQ Copenhagen
stock exchange  CPH:BIOPOR .


Attachment
*     2020 10 21 Announcement no. 20
(https://ml-eu.globenewswire.com/Resource/Download/a051ae7a-88f4-4c4a-8e63-345f98c84196)
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.